The percentages of CD3+, CD4+ and CD8+ T lymphocytes that expressed BTLA were all higher in RA patients than in controls while the percentages of CD3+, CD4+ and CD8+ T lymphocytes that expressed HVEM and LIGHT were all lower in RA patients than those in controls. This evidence concerns the gene CD8A and rheumatoid arthritis.